Sitemap
February 17, 2023 Articles
Filter by Available Specialty
- ‘Intriguing’ data may advance more personalized approach to muscle-invasive bladder cancer
- 31% of adults with chronic pain use medical cannabis
- 31-gene expression profile test guides clinical management of melanoma adjuvant therapies
- Aging plays ‘complex role’ in AMD pathogenesis
- Avacincaptad pegol new drug application receives priority review
- Canadian biotech firm granted exemption to initiate phase 2 psilocybin study
- Comorbid asthma worsens quality of life among patients with allergic rhinitis
- Daily fruit, vegetable intake may reduce mortality in patients with CKD in Japan
- Dronedarone could prevent progression to permanent AF/atrial flutter
- FDA accepts supplemental new drug application for Prevymis for priority review
- FDA approves Lamzede for non-CNS alpha-mannosidosis in adults, children
- FDA approves Syfovre – first treatment for geographic atrophy, a leading cause of blindness
- FDA grants accelerated approval to Filspari for reduced proteinuria in IgA nephropathy
- Free T4, TSH receptor antibodies predict neonatal hypothyroidism in Graves’ disease
- Genetic data reveal hypertensive disorders of pregnancy, CVD link
- Healthy food legislation linked to reduced BMI in children
- Home health care services increased costs without decreasing risk of complications
- Hooked on Rheum with Gwenesta B. Melton, MD
- Hypobaric lidocaine reduced time to discharge for patients undergoing outpatient TJA
- Link between wildfire smoke, preterm birth driven by spontaneous preterm birth
- Long-term ADT does not improve outcomes in high-risk prostate cancer
- Model performs well in predicting suicide attempts across races, ethnicities
- Outpatient HSCT feasible for older adults with AML, myelodysplastic syndrome
- Peanut oral immunotherapy plus omalizumab positively impacts adolescents’ quality of life
- Phase 3 trial of pembrolizumab for prostate cancer misses endpoints
- Plant-based diet may reduce risk for prostate cancer progression
- Point-of-care troponin may be safe, cost-saving method to rule out NSTEACS
- Q&A: Study reveals lack of communication between general practitioners, cardiologists
- Q&A: Machine learning models predict risk for delirium in the ICU
- Q&A: Patients with skin of color experience disparities in dermatology treatment
- Standardized telehealth framework increases patient access to cardiologists
- Study reveals 'substantial incidence' of atrial fibrillation in primary care patients
- Top in rheumatology: COVID-19 vaccination in rituximab users; familial Mediterranean fever
- VIDEO: Costly treatments, lack of insurance hinder care for IBD patients in South Asia
- VIDEO: Novel modulator platform may offer benefit as IOP-lowering agent
- VIDEO: Tear osmolarity an important measure in preoperative ocular assessment
- Volberding: COVID-19, HIV get spotlight at first in-person CROI in 4 years
- Women notably underrepresented in clinical trial leadership
- Women notably underrepresented in clinical trial leadership
- Zelira Therapeutics receives funding for FDA trials of cannabinoid drug for ASD